Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: MeNZB
Active Ingredient: Neisseria meningitidis group B (strain NZ98/254) 25µg/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: Medconsult Services Limited
Manufacturer: Novartis Vaccines and Diagnostics S.r.l, Localita Bellaria, Rosia, Italy
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 9th day of July 2008.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).